Abstract
Currently HLA donor/recipient mismatches are not considered in lung donor allocation or in Scientific Registry of Transplant Recipients (SRTR) risk adjustment for assessing performance of transplant programs. We analyzed patient survival in lung transplant recipients by HLA mismatches (MM).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
